Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP531208.RASaaVDbMgSu-8NN8ng9ao6xj58di9gdCoc6Bny5L4dzg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP531208.RASaaVDbMgSu-8NN8ng9ao6xj58di9gdCoc6Bny5L4dzg130_assertion type Assertion NP531208.RASaaVDbMgSu-8NN8ng9ao6xj58di9gdCoc6Bny5L4dzg130_head.
- NP531208.RASaaVDbMgSu-8NN8ng9ao6xj58di9gdCoc6Bny5L4dzg130_assertion description "[High expression of PLC?1, and of its activated forms, is associated with a worse clinical outcome in terms of incidence of distant metastases, and not of local relapse in T1-T2, N0 breast cancer patients undergone adjuvant chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531208.RASaaVDbMgSu-8NN8ng9ao6xj58di9gdCoc6Bny5L4dzg130_provenance.
- NP531208.RASaaVDbMgSu-8NN8ng9ao6xj58di9gdCoc6Bny5L4dzg130_assertion evidence source_evidence_literature NP531208.RASaaVDbMgSu-8NN8ng9ao6xj58di9gdCoc6Bny5L4dzg130_provenance.
- NP531208.RASaaVDbMgSu-8NN8ng9ao6xj58di9gdCoc6Bny5L4dzg130_assertion SIO_000772 22847294 NP531208.RASaaVDbMgSu-8NN8ng9ao6xj58di9gdCoc6Bny5L4dzg130_provenance.
- NP531208.RASaaVDbMgSu-8NN8ng9ao6xj58di9gdCoc6Bny5L4dzg130_assertion wasDerivedFrom befree-20140225 NP531208.RASaaVDbMgSu-8NN8ng9ao6xj58di9gdCoc6Bny5L4dzg130_provenance.
- NP531208.RASaaVDbMgSu-8NN8ng9ao6xj58di9gdCoc6Bny5L4dzg130_assertion wasGeneratedBy ECO_0000203 NP531208.RASaaVDbMgSu-8NN8ng9ao6xj58di9gdCoc6Bny5L4dzg130_provenance.